Location History:
- Bures s, Yvette, FR (1978)
- Bures-sur-Yvette, FR (1977 - 1984)
Company Filing History:
Years Active: 1977-1984
Title: Edgar Sache: Innovator in Immunoregulation
Introduction
Edgar Sache is a notable inventor based in Bures-sur-Yvette, France. He has made significant contributions to the field of immunology through his innovative patents. With a total of five patents to his name, Sache has focused on developing novel compounds that enhance immune responses.
Latest Patents
One of his latest patents involves the creation of oligomers of compounds of the muramyl-peptide type and medicaments. These novel products are water-soluble oligomers that are free of N-acetyl-glucosamine units. The monomer elements include a group derived from muramic acid, which is fixed with a peptide chain containing at least two aminoacyl residues. The first aminoacyl can be selected from a range of options, including L-alanyl, L-arginyl, and L-phenylalanyl, while the second aminoacyl is either D-glutamyl or D-isoglutaminyl. These compounds are particularly useful for their immunoregulator properties and for the preparation of pharmaceutical compositions. Another significant patent relates to muramyl peptide derivatives and pharmaceutical compositions, which are new compounds that serve as regulators of immune responses.
Career Highlights
Throughout his career, Edgar Sache has worked with various organizations, including Choay, S.A. and the Agence Nationale De Valorisation De La Recherche (ANVAR). His work has been instrumental in advancing the understanding and application of immunoregulation in pharmaceuticals.
Collaborations
Sache has collaborated with notable individuals in his field, including Pierre Lefrancier and Monique Parant. These collaborations have contributed to the development of his innovative ideas and patents.
Conclusion
Edgar Sache's contributions to immunology through his patents highlight his role as a significant inventor in the field. His work continues to influence the development of new pharmaceutical compositions aimed at enhancing immune responses.